Alerts will be sent to your verified email
Verify Email
ISHITADR
|
Ishita Drugs & Inds.
|
Hamps Bio
|
Omkar Pharmachem
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
8.34 % | 17.75 % | 1.16 % |
|
5yr average Equity Multiplier
|
1.24 | 2.66 | 1.07 |
|
5yr Average Asset Turnover Ratio
|
1.36 | 1.39 | 0.04 |
|
5yr Avg Net Profit Margin
|
5.01 % | 5.48 % | -77.87 % |
|
Price to Book
|
2.22 | 0.0 | 2.76 |
|
P/E
|
27.05 | 76.99 | 128.84 |
|
5yr Avg Cash Conversion Cycle
|
40.65 Days | 10.22 Days | 60.23 Days |
|
Inventory Days
|
24.87 Days | 38.15 Days | 0.0 |
|
Days Receivable
|
30.03 Days | 49.29 Days | 60.23 Days |
|
Days Payable
|
48.29 Days | 79.37 Days | 12.54 Days |
|
5yr Average Interest Coverage Ratio
|
25.37 | 3.3 | 3.51 |
|
5yr Avg ROCE
|
11.35 % | 22.28 % | 1.5 % |
|
5yr Avg Operating Profit Margin
|
6.35 % | 15.08 % | -57.26 % |
|
5 yr average Debt to Equity
|
0.03 | 1.2 | 0.08 |
|
5yr CAGR Net Profit
|
6.4 % | 33.03 % | n/a |
|
5yr Average Return on Assets
|
6.76 % | 7.45 % | 1.11 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
49.92 % | 71.99 % | 0.03 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.6 % | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Ishita Drugs & Inds.
|
Hamps Bio
|
Omkar Pharmachem
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|